Testing for her2 in breast cancer: current pathology challenges faced in Canada. | Curr Oncol;19(6): 315-23, 2012 Dec. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Testing for her2 in breast cancer: current pathology challenges faced in Canada.

Hanna, W; Barnes, P; Berendt, R; Chang, M; Magliocco, A; Mulligan, A M; Rees, H; Miller, N; Elavathil, L; Gilks, B; Pettigrew, N; Pilavdzic, D; Sengupta, S.

Affiliation

Hanna W; University of Toronto, Toronto, ON. ; Sunnybrook and Women's College Health Science Centre, University of Toronto, ON.

Curr Oncol ; 19(6): 315-23, 2012 Dec.

Article in En | MEDLINE | ID: mdl-23300357

Key words

breast cancer; her2 testing; pathology

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Systematic_reviews Language: En Journal: Curr Oncol Year: 2012 Document type: Article Country of publication: Switzerland

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Systematic_reviews Language: En Journal: Curr Oncol Year: 2012 Document type: Article Country of publication: Switzerland